TY - JOUR
T1 - Multiple arterial grafts
T2 - Radial versus right internal thoracic arteries
AU - Borger, Michael A.
AU - Cohen, Gideon
AU - Buth, Karen J.
AU - Rao, Vivek
AU - Bozinovski, John
AU - Liaghati-Nasseri, Negin
AU - Mallidi, Hari
AU - Feder-Elituv, Randi
AU - Sever, Jeri
AU - Christakis, George T.
AU - Bhatnagar, Gopal
AU - Goldman, Bernard S.
AU - Cohen, Eric A.
AU - Fremes, Stephen E.
PY - 1998/11/10
Y1 - 1998/11/10
N2 - Background - Left internal thoracic artery (LITA) grafts to the left anterior descending coronary artery (LAD) during coronary bypass surgery (CABG) have greater patency rates than saphenous vein grafts and reduce long- term cardiac morbidity and mortality rates. The benefits of multiple versus single arterial grafts and the role of different arterial conduits with respect to short- and medium-term outcome remains controversial. The purpose of this study was to compare the perioperative and intermediate-term results of: (1) patients receiving 2 arterial grafts versus 1 arterial graft and (2) patients receiving a right internal thoracic artery (RITA) versus a radial artery (RA) as the second arterial graft. Methods: and Results-Retrospective analysis of prospectively gathered data on consecutive patients undergoing isolated CABG at our institution between 1989 and 1996 was conducted. The first section of the study compared outcomes for 1 arterial graft (LITA to LAD, n=2333) versus 2 arterial grafts (LITA + RA or LITA + RITA, n=378). The second section of the study compared outcomes for the RITA (n=132) versus the RA (n=171) as second arterial grafts since 1992, when the radial series was initialed. Part 1: By multivariable stepwise logistic regression, the use of I arterial graft was associated with an increased incidence of perioperative cardiac morbidity and mortality (odds ratio 2.2, 95% confidence interval 1.4 to 3.3), with the use of our current patient selection criteria. Double- arterial graft patients had a nonsignificant trend toward increased intermediate-term actuarial survival (P=0.12) and cardiac event-free survival (P=0.09). Part II: Comparison of preoperative demographics revealed a higher incidence of diabetes (27% vs 11%, P<0.001), peripheral vascular disease (16% vs 8%, P=0.03), and elderly age (13% vs 2%, P=0.001) in patients receiving an RA versus those receiving a RITA as the second arterial graft. Perioperative outcome analysis revealed a decreased intensive care unit stay in the RA versus RITA group (median 30.4 vs 36.2 hours, respectively, P=0.005) but no significant difference in hospital length of stay. There was no significant difference in perioperative mortality or cardiac morbidity rates. RITA patients had a higher incidence of sternal wound infection (5.3% vs 0.6%, P=0.01), however, and tended to have increased blood product transfusion rates (51% vs 40%, P=0.06). Conclusions - The use of 2 arterial grafts is safe, with a reduction in perioperative cardiac morbidity or mortality rates compared with 1 arterial graft after adjustment for other risk variables. When comparing RITA to RA as second arterial grafts, patients receiving an RA have a lower incidence of sternal wound infection and decreased transfusion requirements, with no difference in perioperative or intermediate-term cardiac morbidity or mortality rates.
AB - Background - Left internal thoracic artery (LITA) grafts to the left anterior descending coronary artery (LAD) during coronary bypass surgery (CABG) have greater patency rates than saphenous vein grafts and reduce long- term cardiac morbidity and mortality rates. The benefits of multiple versus single arterial grafts and the role of different arterial conduits with respect to short- and medium-term outcome remains controversial. The purpose of this study was to compare the perioperative and intermediate-term results of: (1) patients receiving 2 arterial grafts versus 1 arterial graft and (2) patients receiving a right internal thoracic artery (RITA) versus a radial artery (RA) as the second arterial graft. Methods: and Results-Retrospective analysis of prospectively gathered data on consecutive patients undergoing isolated CABG at our institution between 1989 and 1996 was conducted. The first section of the study compared outcomes for 1 arterial graft (LITA to LAD, n=2333) versus 2 arterial grafts (LITA + RA or LITA + RITA, n=378). The second section of the study compared outcomes for the RITA (n=132) versus the RA (n=171) as second arterial grafts since 1992, when the radial series was initialed. Part 1: By multivariable stepwise logistic regression, the use of I arterial graft was associated with an increased incidence of perioperative cardiac morbidity and mortality (odds ratio 2.2, 95% confidence interval 1.4 to 3.3), with the use of our current patient selection criteria. Double- arterial graft patients had a nonsignificant trend toward increased intermediate-term actuarial survival (P=0.12) and cardiac event-free survival (P=0.09). Part II: Comparison of preoperative demographics revealed a higher incidence of diabetes (27% vs 11%, P<0.001), peripheral vascular disease (16% vs 8%, P=0.03), and elderly age (13% vs 2%, P=0.001) in patients receiving an RA versus those receiving a RITA as the second arterial graft. Perioperative outcome analysis revealed a decreased intensive care unit stay in the RA versus RITA group (median 30.4 vs 36.2 hours, respectively, P=0.005) but no significant difference in hospital length of stay. There was no significant difference in perioperative mortality or cardiac morbidity rates. RITA patients had a higher incidence of sternal wound infection (5.3% vs 0.6%, P=0.01), however, and tended to have increased blood product transfusion rates (51% vs 40%, P=0.06). Conclusions - The use of 2 arterial grafts is safe, with a reduction in perioperative cardiac morbidity or mortality rates compared with 1 arterial graft after adjustment for other risk variables. When comparing RITA to RA as second arterial grafts, patients receiving an RA have a lower incidence of sternal wound infection and decreased transfusion requirements, with no difference in perioperative or intermediate-term cardiac morbidity or mortality rates.
UR - http://www.scopus.com/inward/record.url?scp=0344269353&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0344269353&partnerID=8YFLogxK
M3 - Article
C2 - 9852873
AN - SCOPUS:0344269353
SN - 0009-7322
VL - 98
SP - II7-II14
JO - Circulation
JF - Circulation
IS - 19 SUPPL.
ER -